Recent Quotes
My Watchlist
Indicators
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GlucoTrack, Inc. - Common Stock (NQ:GCTK)

0.3474 +0.0058 (+1.70%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 697,605
Open 0.3378
Bid (Size) 0.3305 (300)
Ask (Size) 0.3339 (3,000)
Prev. Close 0.3416
Today's Range 0.3303 - 0.3698
52wk Range 0.2500 - 14.14
Shares Outstanding 910,688
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Continued Collaboration with the University of Georgia
From Lōkahi Therapeutics
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Gainers INVO Fertility (NASDAQ:IVF) shares increased by 163.4% to $2.56 during Monday's pre-market session. The company's market cap stands at $1.7 million. GlucoTrack (NASDAQ:GCTK) shares moved... 
Via Benzinga

Performance

YTD
-91.0%
-91.0%
1 Month
+13.6%
+13.6%
3 Month
-30.5%
-30.5%
6 Month
-77.3%
-77.3%
1 Year
-93.6%
-93.6%

More News

Read More
News headline image
Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation
From Glucotrack, Inc.
Via Business Wire
News headline image
Glucotrack Announces $5.5 Million Financing
From Glucotrack
Via Business Wire
What's going on in today's after hours session ↗
Via Chartmill
News headline image
CORRECTING and REPLACING Lōkahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline
From Lōkahi Therapeutics Inc.
Via Business Wire
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
Thursday's after hours session: top gainers and losers ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
Here are the top movers in Thursday's session. ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration
From Lōkahi Therapeutics Inc.
Via Business Wire
What's going on in today's pre-market session ↗
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
News headline image
Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives
From Glucotrack, Inc.; Lōkahi Therapeutics
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
UPDATE – Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform
From Glucotrack, Inc.; Lōkahi Therapeutics
Via GlobeNewswire
News headline image
Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform
From Glucotrack, Inc.; Lōkahi Therapeutics
Via GlobeNewswire
News headline image
Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform
From Glucotrack, Inc.
Via GlobeNewswire
Top movers in Thursday's after hours session ↗
Via Chartmill
News headline image
Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions
From Glucotrack, Inc.
Via GlobeNewswire
News headline image
Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology
From Glucotrack, Inc.
Via GlobeNewswire
Wednesday's session: most active stocks ↗
Via Chartmill

Frequently Asked Questions

Is GlucoTrack, Inc. - Common Stock publicly traded?
Yes, GlucoTrack, Inc. - Common Stock is publicly traded.
What exchange does GlucoTrack, Inc. - Common Stock trade on?
GlucoTrack, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GlucoTrack, Inc. - Common Stock?
The ticker symbol for GlucoTrack, Inc. - Common Stock is GCTK on the Nasdaq Stock Market
What is the current price of GlucoTrack, Inc. - Common Stock?
The current price of GlucoTrack, Inc. - Common Stock is 0.3474
When was GlucoTrack, Inc. - Common Stock last traded?
The last trade of GlucoTrack, Inc. - Common Stock was at 08/21/26 04:00 PM ET
What is the market capitalization of GlucoTrack, Inc. - Common Stock?
The market capitalization of GlucoTrack, Inc. - Common Stock is 316.37K
How many shares of GlucoTrack, Inc. - Common Stock are outstanding?
GlucoTrack, Inc. - Common Stock has 316K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>